Lentiviral vectors targeted to MHC II are effective in immunization

Human Gene Therapy

Volumn 22, Issue 10, 2011, Pages 1249-1254

  Ageichik, Alexander ^a   Buchholz, Christian J ^b   Collins, Mary K ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEASLES VIRUS HEMAGGLUTININ; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG RECEPTOR BINDING; GENE MUTATION; GENE TARGETING; GENETIC IMMUNIZATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MEASLES VIRUS; MOUSE; NONHUMAN; SPLEEN CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSPOT ASSAY; GENES, MHC CLASS II; GENETIC VECTORS; HEMAGGLUTININS; IMMUNIZATION; LENTIVIRUS; MEASLES VIRUS; MICE; TRANSDUCTION, GENETIC;

MEASLES VIRUS; MURINAE;

EID: 80155145278     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.184     Document Type: Article

References (29)

1. Anliker, B., Abel, T., Kneissel, S., et al. (2010). Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat. Methods 7, 929-935.
2. Arce, F., Rowe, H.M., Chain, B., et al. (2009). Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Mol. Ther. 17, 1643-1650.
3. Beignon, A.S., Mollier, K., Liard, C., et al. (2009). Lentiviral vectorbased prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques. J. Virol. 83, 10963-10974.
4. Bonifaz, L.C., Bonnyay, D.P., Charalambous, A., et al. (2004). In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824. (Pubitemid 38375201)
5. Breckpot, K., Escors, D., Arce, F., et al. (2010). HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J. Virol. 84, 5627-5636.
6. Chowdhury, S., Chester, K.A., Bridgewater, J., et al. (2004). Efficient retroviral vector targeting of carcinoembryonic antigenpositive tumors. Mol. Ther. 9, 85-92. (Pubitemid 38208331)
7. Coutant, F., Frenkiel, M.P., Despres, P., and Charneau, P. (2008). Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One 3, e3973.
8. Dai, B., Yang, L., Yang, H., et al. (2009). HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20382-20387.
9. Escors, D., Lopes, L., Lin, R., et al. (2008). Targeting dendritic cell signaling to regulate the response to immunization. Blood 111, 3050-3061.
10. Esslinger, C., Chapatte, L., Finke, D., et al. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J. Clin. Invest. 111, 1673-1681. (Pubitemid 38057749)
11. Frecha, C., Costa, C., Levy, C., et al. (2009). Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood 114, 3173-3180.
12. Funke, S., Maisner, A., Muhlebach, M.D., et al. (2008). Targeted cell entry of lentiviral vectors. Mol. Ther. 16, 1427-1436.
13. Furmanov, K., Elnekave, M., Lehmann, D., et al. (2010). The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors. J. Immunol. 184, 4889-4897.
14. Gennari, F., Lopes, L., Verhoeyen, E., et al. (2009). Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells. Hum. Gene Ther. 20, 554-562.
15. He, Y., Zhang, J., Donahue, C., and Falo, L.D., Jr. (2006). Skinderived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24, 643-656.
16. Lechler, R.I., Ronchese, F., Braunstein, N.S., and Germain, R.N. (1986). I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer. J. Exp. Med. 163, 678-696. (Pubitemid 16141970)
17. Loisel-Meyer, S., Felizardo, T., Mariotti, J., et al. (2009). Potent induction of B-and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection. Mol. Cancer Ther. 8, 692-702.
18. Lopes, L., Dewannieux, M., Gileadi, U., et al. (2008). Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. J. Virol. 82, 86-95. (Pubitemid 350309126)
19. Morizono, K., Xie, Y., Ringpis, G.E., et al. (2005). Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat. Med. 11, 346-352. (Pubitemid 40460565)
20. Morizono, K., Ku, A., Xie, Y., et al. (2010). Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins. J. Virol. 84, 6923-6934.
21. Nchinda, G., Kuroiwa, J., Oks, M., et al. (2008). The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J. Clin. Invest. 118, 1427-1436. (Pubitemid 351500436)
22. Palmowski, M.J., Lopes, L., Ikeda, Y., et al. (2004). Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. J. Immunol. 172, 1582-1587. (Pubitemid 38116804)
23. Rowe, H.M., Lopes, L., Ikeda, Y., et al. (2006). Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Mol. Ther. 13, 310-319. (Pubitemid 43056896)
24. Sandrin, V., Russell, S.J., and Cosset, F.L. (2003). Targeting retroviral and lentiviral vectors. Curr. Top. Microbiol. Immunol. 281, 137-178. (Pubitemid 36950685)
25. Tacken, P.J., Torensma, R., and Figdor, C.G. (2006). Targeting antigens to dendritic cells in vivo. Immunobiology 211, 599-608.
26. Thacker, E.E., Nakayama, M., Smith, B.F., et al. (2009). A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine 27, 7116-7124.
27. VandenDriessche, T., Thorrez, L., Naldini, L., et al. (2002). Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100, 813-822. (Pubitemid 34832606)
28. Yang, L., Bailey, L., Baltimore, D., and Wang, P. (2006). Targeting lentiviral vectors to specific cell types in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 11479-11484. (Pubitemid 44182477)
29. Yang, L., Yang, H., Rideout, K., et al. (2008). Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat. Biotechnol. 26, 326-334. (Pubitemid 351355129)